{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:29:01Z","timestamp":1784204941228,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Fulminant <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia (FMPP) accounts for 0.5\u20132% of all MPP cases, which is considered as MPP combined with severe complications such as hypoxemia, acute respiratory distress syndrome, or acute respiratory failure. It primarily affects young adults with no underlying disease. Although some studies have proved the severity of FMPP, the details about clinical diagnosis and treatment of FMPP in children have been rarely reported. In this case study, we described three cases who suffered from FMPP. These children not only developed acute lung injury and multiple organ involvement within 7 days of treatment, but were also found plastic bronchitis by bronchoscopy. Finally, all the patients were treated successfully with azithromycin, glucocorticoid, and bronchoscopy lavage. We conclude that this case study would contribute to raise awareness with respect to FMPP, which may occur at a younger age with faster disease progression and common extrapulmonary manifestations. It also reinforces the importance of early identification and prompt intervention to save life of children and reduces sequelae. Further studies are needed about mechanism of FMPP.<\/jats:p>","DOI":"10.3389\/fped.2021.741663","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T13:08:21Z","timestamp":1639055301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children"],"prefix":"10.3389","volume":"9","author":[{"given":"Tongqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunquan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.23736\/S0026-4946.16.04866-0","article-title":"Diagnosis and treatment of Mycoplasma pneumoniae in children","volume":"69","author":"Rogozinski","year":"2017","journal-title":"Minerva Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","article-title":"Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019","volume":"120","author":"Lee","year":"2021","journal-title":"J Formos Med Assoc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3389\/fmicb.2016.00800","article-title":"Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia","volume":"7","author":"Izumikawa","year":"2016","journal-title":"Front Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e21128","DOI":"10.1097\/MD.0000000000021128","article-title":"Tigecycline in the treatment of fulminant Mycoplasma pneumoniae pneumonia non-responsive to azithromycin and fluoroquinolone: A case report","volume":"99","author":"Yuan","year":"2020","journal-title":"Medicine."},{"key":"B5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/cid\/cir769","article-title":"Fatal outcomes in family transmission of Mycoplasma pneumoniae","volume":"54","author":"Kannan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/INF.0000000000001628","volume":"36","author":"Inchley","year":"2017","journal-title":"Mycoplasma pneumoniae: a cross-sectional population-based comparison of disease severity in pre-school and school-age children. Pediatric Infectious Disease Journal"},{"key":"B7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3345\/kjp.2015.58.6.211","article-title":"Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study","volume":"58","author":"Kim","year":"2015"},{"key":"B8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.4103\/0377-4929.68283","article-title":"A fulminant case of acute respiratory distress syndrome associated with Mycoplasma pneumoniae infection","volume":"53","author":"Kapoor","year":"2010"},{"key":"B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jiac.2013.09.009","article-title":"Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2342-9-7","article-title":"Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing","volume":"9","author":"Miyashita","year":"2009","journal-title":"BMC Med Imaging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1099\/jmm.0.47119-0","article-title":"Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit","volume":"56","author":"Miyashita","year":"2007","journal-title":"J Med Microbiol."},{"key":"B12","first-page":"305","article-title":"Mycoplasma pneumonia associated with rhabdomyolysis and the Guillain-Barre syndrome","volume":"47","author":"Gupta","year":"2005","journal-title":"Indian J Chest Dis Allied Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3760\/cma.j.issn.0578-1310.2014.10.016","article-title":"Analysis of 3 cases with Mycoplasma pneumoniae-associated hemophagocytic syndrome and review of literature","volume":"52","author":"Lu","year":"2014","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2334-11-162","article-title":"Overwhelming postsplenectomy infection due to Mycoplasma pneumoniaein an asplenic cirrhotic patient: Case report","volume":"11","author":"Xu","year":"2011","journal-title":"BMC Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.7499\/j.issn.1008-8830.2003182","article-title":"Influencing factors for the clinical effect of bronchoalveolar lavage in children with Mycoplasma pneumoniae pneumonia and atelectasis","volume":"22","author":"Long","year":"2020","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"B16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1183\/09031936.02.00113202","article-title":"Flexible endoscopy of paediatric airways","volume":"22","author":"Midulla","year":"2003","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1164\/rccm.201503-0474ST","article-title":"Official American Thoracic Society technical standards: flexible airway endoscopy in children","volume":"191","author":"Faro","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3760\/cma.j.issn.2095-428X.2018.22.004","article-title":"Risk factors of multiple bronchoscope lavage therapy in children with refractory Mycoplasma pneumoniae pneumonia","volume":"5","author":"Zhang","year":"2020","journal-title":"Chin J Appl Clin Pediatr 2018"},{"key":"B19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12879-020-05085-5","article-title":"Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers","volume":"20","author":"Ding","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B20","first-page":"471","article-title":"A case of fulminant Mycoplasma pneumoniae pneumonia despite adequate antibiotic treatment","volume":"47","author":"Kosugi","year":"2009","journal-title":"Nihon Kokyuki Gakkai zasshi."},{"key":"B21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae pneumonia in Children","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4168\/aair.2014.6.1.3","article-title":"The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma pneumonia in Children","volume":"6","author":"Jae-Won","year":"2014","journal-title":"Allergy Asthma & Immunology Research"},{"key":"B24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3760\/cma.j.issn.0578-1310.2015.10.015","article-title":"Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels","volume":"53","author":"Lan","year":"2015","journal-title":"Zhonghua Er Ke Za Zhi Chinese Journal of Pediatrics."},{"key":"B25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12879-021-05830-4","article-title":"Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy","volume":"21","author":"Zhu","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3947\/ic.2014.46.4.239","article-title":"Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study","volume":"46","author":"Youn","year":"2014","journal-title":"Infect Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ppul.22650","article-title":"Combination therapy with immune-modulators and moxifloxacin on fulminant macrolide-resistant Mycoplasma pneumoniae infection: A case report","volume":"48","author":"Shen","year":"2013","journal-title":"Pediatr Pulmonol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.741663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T13:08:32Z","timestamp":1639055312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.741663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":27,"alternative-id":["10.3389\/fped.2021.741663"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.741663","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"article-number":"741663"}}